Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist representation of a drug molecule in flat design.

Jul 15, 2026

OpenAI Researcher Miles Wang Eyes $2B AI Drug Discovery Startup

OpenAI researcher Miles Wang is poised to launch an AI-driven drug discovery startup valued at $2 billion, marking a significant trend in biotech investment.Wang's venture is reportedly in advanced discussions with Lightspeed Venture Partners, which aims to lead a funding round that could become one of the largest in the biotech sector. This initiative highlights the growing investor confidence in AI's ability to transform pharmaceutical development, particularly in drug discovery, which traditi
A diagnostic tool on a workbench in a vehicle workshop

Jul 15, 2026

Vector Launches End-to-End SOVD Toolchain for Next-Generation Vehicle Diagnostics

Vector has launched an innovative end-to-end toolchain for Service-Oriented Vehicle Diagnostics (SOVD), aimed at enhancing the efficiency of vehicle diagnostics for manufacturers and suppliers.The SOVD technology standardizes diagnostic data into services utilizing internet protocols like HTTP and REST APIs, addressing the growing need for remote diagnostics and over-the-air updates in modern vehicles. This toolchain combines existing diagnostic tools with new technologies, facilitating a compre
A minimalist illustration of a 3D organ printer and an organ silhouette.

Jul 14, 2026

Bar-Ilan University and Sheba Medical Center Joining Forces for Biotech Innovation Institute With $120 Million Investment

Bar-Ilan University and Sheba Medical Center are launching a pioneering biotech research institute with a significant $120 million investment aimed at expediting the transition from laboratory discoveries to clinical applications.The newly established institute, which will be located in Sheba's Health Tech Valley in Ramat Gan, is designed to focus on critical areas such as cancer research, AI diagnostics, 3D organ printing, robotics, and microbiome science. This initiative draws inspiration from
A molecular model on a lab bench in a research laboratory

Jul 14, 2026

Chai Discovery Raises $400 Million Series C To Advance AI-Driven Molecular Design

Chai Discovery has successfully secured $400 million in Series C funding, propelling its AI-driven molecular design platform toward enhanced drug discovery capabilities.The financing round, which values the company at $3.8 billion, was spearheaded by Index Ventures and included significant participation from other notable investors such as Kleiner Perkins, Sequoia Capital, and Bain Capital Ventures. Existing backers, including OpenAI and Thrive Capital, also contributed to this substantial inves
Minimalist representation of cloud architecture and compliance in pharma

Jul 14, 2026

Why Integration, Not AI, May Be the Most Important Factor in Pharma’s ERP Journey

As pharmaceutical companies evolve their Enterprise Resource Planning (ERP) systems, the focus is shifting from artificial intelligence (AI) to the foundational elements of integration and governance. Recent research indicates that effective integration, cloud architecture, and regulatory compliance are critical for operational success before AI can be effectively implemented.The trend towards adopting SAP S/4HANA Cloud is often linked to AI advancements, yet the reality is that many life scienc
A minimalist illustration of a stethoscope and heart symbolizing healthcare leadership.

Jul 14, 2026

Anumeha Srivastava Appointed Chief Executive Officer – Digital Health Joint Venture at Biological E. Limited

Biological E. Limited has appointed Anumeha Srivastava as the new Chief Executive Officer of its Digital Health Joint Venture, signaling a strategic move towards integrating AI and digital innovation in healthcare.In her role, Srivastava will guide the joint venture's strategic initiatives, focusing on the application of advanced technologies to enhance healthcare solutions. Her appointment follows a notable six-year tenure at Qure.ai, where she was instrumental in driving global commercial grow
A biological data sample on a lab bench in a dimly lit research lab

Jul 14, 2026

Honoring the Innovators Driving AI’s Next Era in Life Sciences and Healthcare

A recent event in London, the “AI Discovery Awards” sponsored by Nebius, showcased innovative startups in the life sciences sector utilizing AI to enhance healthcare. The awards highlighted advancements in biopharma, genomics, medical devices, and digital health, emphasizing the critical role of AI in driving medical breakthroughs.During a pre-awards discussion, researchers underscored the necessity of robust computing infrastructure and high-quality biological data for effective AI applications
A document and pen on a desk in a dimly lit office setting.

Jul 14, 2026

Silo Pharma, Inc. (SILO) Stock: Slide 4.92% as QwikAgents Joins AMD AI Developer Program

Silo Pharma, Inc. (SILO) experienced a 4.92% decline in stock price, settling at $5.02, following the announcement that its subsidiary QwikAgents has joined AMD’s AI Developer Program.The partnership with AMD aims to enhance QwikAgents' capabilities by providing access to cloud resources, development tools, and technical support. This collaboration is designed to improve the platform's testing, optimization, and deployment processes, which focus on automated digital agents for various tasks, inc
Minimalist illustration of an AI agent

Jul 14, 2026

Why Is Silo Pharma Stock Volatile Today? - SILO Pharma (NASDAQ:SILO)

Silo Pharma's stock experienced fluctuations on Tuesday, initially rising before declining into negative territory.The company announced its participation in a program aimed at enhancing the development and optimization of QwikAgents, an artificial intelligence platform. This initiative is set to expand the platform's capabilities for both consumers and enterprises, targeting a range of users from individuals to developers and businesses. QwikAgents will allow users to deploy customizable AI age
A stock certificate and financial report on a wooden desk

Jul 14, 2026

Silo Pharma (SILO) Shares Drop 4.92% Following QwikAgents' Entry into AMD AI Developer Program

Silo Pharma's shares fell by 4.92% to $5.02 following the announcement of QwikAgents' entry into AMD's AI Developer Program, despite the potential benefits of the partnership.The decline in Silo Pharma's stock price reflects market reactions to the news that its subsidiary, QwikAgents, has joined AMD’s AI Developer Program. This membership grants QwikAgents access to advanced cloud infrastructure and development resources aimed at enhancing its automation platform capabilities. The stock experie
Flat illustration of a capsule and a cancer cell

Jul 14, 2026

Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics

This week saw significant partnership developments in the pharma and biotech sectors, particularly in oncology and AI-driven drug discovery.AstraZeneca has secured global rights to Zegfrovy (sunvozertinib) through a licensing agreement with Dizal Pharmaceutical. This oral EGFR inhibitor is approved for adult patients with specific mutations in non-small cell lung cancer (NSCLC) who have progressed after chemotherapy. AstraZeneca's investment includes an upfront payment of $600 million, with pote
A minimalist illustration of a satellite with a laser beam in space.

Jul 14, 2026

Europe Risks Reliance on Foreign Space Networks Unless It Scales Optical Connectivity

Experts emphasize the necessity for Europe to enhance its optical communication capabilities to maintain competitiveness in the space sector, particularly against established networks like Starlink.As Europe invests significantly in its sovereign space initiatives, including the IRIS2 satellite constellation and a substantial defense budget, experts caution that merely developing infrastructure is insufficient. To achieve true autonomy and competitiveness, Europe must prioritize scaling optical